Skip to main content
. 2017 May 19;8(43):73860–73870. doi: 10.18632/oncotarget.18008

Figure 2.

Figure 2

(A) Positive expression of P57/Kip2 in the adjacent non-cancerous tissues (×20). (B) Positive expression of P57/Kip2 in the adjacent non-cancerous tissues(×40). (C) Negative expression of P57/Kip2 in GCA (×20). (D) Negative expression of P57/Kip2 in GCA(×40). (E) Negative expression of CyclinD1 in the adjacent non-cancerous tissues(×20). (F) Negative expression of CyclinD1 in the adjacent non-cancerous tissues(×40). (G) Positive expression of CyclinD1 in GCA(×20). (H) Positive expression of CyclinD1 in GCA(×40).